Description
(Part-1-Science) Synthetic cannabinoid production has been on people's radar for some time. The question is, can it emerge as the dominant supplier of cannabinoids in the cannabis, hemp, pharma or international markets?
Not all synthetic cannabinoids are the same, we discuss a “biosynthetic” approach using unique algae strains with our guest, Rob Evans, Co-Founder of Purissima.
Chapters:
00:00 - Intro, Rob’s Chemistry Background
05:56 - Why are synthetic molecules bad?
10:48 - What cannabinoids can be made
14:08 - Do certain molecules have limits?
18:48 - Engineering Algae Strains
27:27 - Production quality control process
31:00 - Part 2 Business
🟠 SHOP our Effects-Based Edibles
🟠 10% OFF your 1st order, Use Code = PODCAST
https://www.periodiccaramels.com/shop-edibles
Watch our YouTube Channel:
https://www.youtube.com/c/PeriodicEffects
Free Consulting Call w/ Wayne:
https://calendly.com/periodic-wayne/call?month=2022-05
What’s next for this podcast? Does it live on? Or come to its eventual end, as all things eventually do?
🟠 Please take our Podcast Survey to give us your insights 👍
🟠 https://forms.gle/nYABBT8XurRbGh4t7
In this episode, I discuss our edible business behind-the-scenes, how things have changed,...
Published 05/19/23
[Consulting Call] In 2022, the FDA issued more warning letters to CBD companies than ever. To address this, Graham Lipsman, an engineer and eCommerce consultant, developed a tool for cannabis and hemp companies called Simple Certs.
Will it work as a compliance tool? Should it pivot to a...
Published 04/19/23